Protein detail

SPP2A

Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2)

Entry name
SPP2A
UniProt ID
EVMP confidence score
0.63
Supporting publications (n)
27
Transmembrane count
9
Protein classification
Disease related genesEnzymesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2)
Protein Class (7)
Disease related genesEnzymesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters
Protein Function (6)
  • Potential drug targets
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Enzymes
  • Transporters:Transporter channels and pores
  • Disease related genes
  • Peptidases:Aspartic-type peptidases
Transmembrane
173..193; Helical; 221..241; Helical; 248..268; Helical; 286..306; Helical; 312..332; Helical; 341..361; Helical; 400..420; Helical; 438..458; Helical; 461..481; Helical
Transmembrane Count
9
Entrez Gene Symbol
Gene Synonym (2)
IMP3PSL2
Gene Description
Signal peptide peptidase like 2A
Chromosome
15
Position
50702266-50765948
Supporting publications (n)
27
EVMP confidence score
0.63
Fluorescence & Localization2
Tissue Specificblood vesselCell SpecificThymocytes
Function & Pathway7
Protein Function (6)
  • Potential drug targets
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Enzymes
  • Transporters:Transporter channels and pores
  • Disease related genes
  • Peptidases:Aspartic-type peptidases
Canonical Pathways (3)
  • M240 Pid syndecan 2 pathway
  • M276 Pid fgf pathway
  • M100 Pid shp2 pathway
Mediation Categories (3)
Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation
Relations & Evidence19

Ligand-Receptor Signaling (18)

18 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
extracellularextracellularOmniPathNoNoNoYesNo
intracellularintracellularLOCATENoNoNoYesNo
intracellularintracellularComPPINoNoNoYesNo
intracellularintracellularGO_IntercellNoNoNoYesNo
intracellularintracellularUniProt_locationNoNoNoYesNo
intracellularintracellularOmniPathNoNoNoYesNo
transmembranetransmembraneUniProt_locationNoNoNoYesNo
transmembranetransmembraneUniProt_topologyNoNoNoYesNo
transmembranetransmembraneUniProt_keywordNoNoNoYesNo
transmembranetransmembraneTopDBNoNoNoYesNo
Page 1 of 2Next

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyImmunoaffinity CaptureR SequencingMass spectrometry233371834239290459399494903150850038225453398737263887173032795414268019192772398430071318337095103097589437686366400983463076053831366407403116164009145533114768304513714131576731320591
Sequence, Structure & Domains8

Sequences

Length
520
Mass
58,143
Sequence
MGPQRRLSPAGAALLWGFLLQLTAAQEAILHASGNGTTKDYCMLYNPYWTALPSTLENATSISLMNLTSTPLCNLSDIPPVGIKSKAVVVPWGSCHFLEKARIAQKGGAEAMLVVNNSVLFPPSGNRSEFPDVKILIAFISYKDFRDMNQTLGDNITVKMYSPSWPNFDYTMVVIFVIAVFTVALGGYWSGLVELENLKAVTTEDREMRKKKEEYLTFSPLTVVIFVVICCVMMVLLYFFYKWLVYVMIAIFCIASAMSLYNCLAALIHKIPYGQCTIACRGKNMEVRLIFLSGLCIAVAVVWAVFRNEDRWAWILQDILGIAFCLNLIKTLKLPNFKSCVILLGLLLLYDVFFVFITPFITKNGESIMVELAAGPFGNNEKLPVVIRVPKLIYFSVMSVCLMPVSILGFGDIIVPGLLIAYCRRFDVQTGSSYIYYVSSTVAYAIGMILTFVVLVLMKKGQPALLYLVPCTLITASVVAWRRKEMKKFWKGNSYQMMDHLDCATNEENPVISGEQIVQQ

Domain & Motif Annotations

Motif
463..465; PAL; 495..498; YXXo lysosomal targeting motif
Domain (CC)
The PAL motif is required for normal active site conformation. The catalytic domains embedded in the membrane are in the opposite orientation to that of the presenilin protein family; therefore, it is predicted to cleave type II-oriented substrate peptides like the prototypic protease SPP. The C-terminal tail is necessary for lysosomal transport.
Domain (FT)
63..151; PA
Protein Families
Peptidase A22B family
Sequence Similarities
Belongs to the peptidase A22B family.
Clinical Relevance2
Drug Targets
Literature-reported target
Supporting Publications27
PMIDTitleAbstract
32795414Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.Among traditional exosome markers, CD9, HSPA8, ALIX, and HSP90AB1 represent pan-EVP markers, while ACTB, MSN, and RAP1B are novel pan-EVP markers.
33580265Proteomic Profile of Urinary Extracellular Vesicles Identifies AGP1 as a Potential Biomarker of Primary Aldosteronism.No abstract available
33709510Unbiased proteomic profiling of host cell extracellular vesicle composition and dynamics upon HIV-1 infection.No abstract available
36332889A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles.No abstract available
36406491Automated Proteomics Sample Preparation of Phosphatidylserine-Positive Extracellular Vesicles from Human Body Fluids.No abstract available
37686366Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.No abstract available
37862381Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4.No abstract available
37922300Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.No abstract available
38225453Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions.No abstract available
38490958Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.No abstract available
Page 2 of 3PreviousNext